1. Home
  2. FULC vs NMG Comparison

FULC vs NMG Comparison

Compare FULC & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • NMG
  • Stock Information
  • Founded
  • FULC 2015
  • NMG 2011
  • Country
  • FULC United States
  • NMG Canada
  • Employees
  • FULC N/A
  • NMG N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • NMG Other Metals and Minerals
  • Sector
  • FULC Health Care
  • NMG Basic Materials
  • Exchange
  • FULC Nasdaq
  • NMG Nasdaq
  • Market Cap
  • FULC 468.1M
  • NMG 448.1M
  • IPO Year
  • FULC 2019
  • NMG 2017
  • Fundamental
  • Price
  • FULC $11.74
  • NMG $2.65
  • Analyst Decision
  • FULC Buy
  • NMG Strong Buy
  • Analyst Count
  • FULC 7
  • NMG 3
  • Target Price
  • FULC $10.43
  • NMG $4.22
  • AVG Volume (30 Days)
  • FULC 922.1K
  • NMG 812.2K
  • Earning Date
  • FULC 10-29-2025
  • NMG 11-12-2025
  • Dividend Yield
  • FULC N/A
  • NMG N/A
  • EPS Growth
  • FULC N/A
  • NMG N/A
  • EPS
  • FULC N/A
  • NMG N/A
  • Revenue
  • FULC N/A
  • NMG N/A
  • Revenue This Year
  • FULC N/A
  • NMG N/A
  • Revenue Next Year
  • FULC N/A
  • NMG N/A
  • P/E Ratio
  • FULC N/A
  • NMG N/A
  • Revenue Growth
  • FULC 2752.05
  • NMG N/A
  • 52 Week Low
  • FULC $2.32
  • NMG $1.22
  • 52 Week High
  • FULC $12.14
  • NMG $6.06
  • Technical
  • Relative Strength Index (RSI)
  • FULC 72.74
  • NMG 45.61
  • Support Level
  • FULC $7.51
  • NMG $2.60
  • Resistance Level
  • FULC $9.05
  • NMG $3.59
  • Average True Range (ATR)
  • FULC 0.80
  • NMG 0.34
  • MACD
  • FULC 0.27
  • NMG -0.01
  • Stochastic Oscillator
  • FULC 89.63
  • NMG 26.54

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About NMG Nouveau Monde Graphite Inc.

Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.

Share on Social Networks: